按類型、工具和地區分類的計算生物學市場

Computational Biology Market, By Type, By Tools,and By Region

出版日期: 2025年07月07日 | 出版商:

Coherent Market Insights | 英文 160 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

計算生物學市場在 2025 年的價值估計為 91.3 億美元，預計到 2032 年將達到 284 億美元，2025 年至 2032 年的年複合成長率（CAGR）為 17.6%。

報告範圍		報告詳細資訊
基準年	2024	2025年的市場規模	91.3億美元
效能數據	2020-2024	預測期	2025-2032
預測期：2025-2032年	17.60%	2032年預測	284億美元

計算生物學旨在透過開發疾病的計算模型、使用患者數據對這些模型進行個人化設定以及應用這些模型來改善疾病的診斷和治療，從而改善醫療保健。這些患者模型用於發現新的風險生物標記、預測疾病進展、設計最佳治療方法以及識別癌症、心血管疾病和神經系統疾病等應用中的新藥物標靶。患者特異性定量模型的開發和應用可用於理解、診斷和治療疾病。計算醫學可用於分子醫學、生理醫學和解剖醫學。透過整合生物醫學訊號處理、計算建模、機器學習和健康資訊學，可以利用電子健康記錄、生理時間序列資料和基因組學開發個人化醫療的新方法。

市場動態

預計主要市場參與企業不斷增加的新產品發布、併購將推動全球計算生物學市場的成長。例如，2022 年 7 月 25 日，美國基因組編寫公司 Replay 籌集了 5,500 萬美元的種子資金。此輪融資由 KKR 和 OMX Ventures主導，ARTIS Ventures、Lansdowne Partners、SALT、DeliBio Ventures 和 Axial 參投。 Replay 的基因組醫學套件包包括一系列用於編寫和遞送大型 DNA 片段的顛覆性平台技術，包括高有效載荷容量的 HSV 遞送平台、低免疫抗原性細胞療法平台和專有基因組編寫平台。美國基因組編寫公司 Replay 解決了目前限制臨床進展的挑戰，包括提高有效載荷容量；降低商品成本的現成細胞療法；提高生產速度、產量和一致性；以及擴展基因組工程能力。

本次調查的主要特點

本報告對全球計算生物學市場進行了詳細分析，展示了預測期 2025 年至 2032 年的市場規模（十億美元）和年複合成長率（CAGR），以 2024 年為基準年。
它還強調了各個領域的潛在商機，並說明了該市場的有吸引力的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的主要考察。
它根據公司亮點、產品系列、關鍵亮點、財務表現和策略等參數概述了全球計算生物學市場的主要企業。
本研究涉及的主要企業包括 Accelrys、Certara、LP、Chemical Computing Group Inc.、Compugen、Ltd.、Entelos、Inc. (Rosa & Co. LLC)、Genedata AG、Insilico BIoTechnology AG、Leadscope、Inc.、Nimbus Discovery LLC、Rhenovia ology AG、Leadscope、Inc.、Nimbus Discovery LLC、Rhenovia ology AG、Leadscope、Inc.、Nimbus Discovery LLC、Rhenovia ology AG.
本報告的見解將使負責人和企業經營團隊能夠就未來的產品發布、最新策略、市場擴張和行銷策略做出明智的決策。
本研究報告針對該產業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
相關人員可以透過用於全球計算生物學市場分析的各種策略矩陣更輕鬆地做出決策。

介紹
北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 東南亞國協
- 澳洲
- 韓國
- 其他亞太地區
中東
- 海灣合作理事會國家
- 以色列
- 其他中東地區
非洲
- 北非
- 中部非洲
- 南非

第7章競爭態勢

Accelrys
Certara, LP
Chemical Computing Group Inc.
Compugen, ltd.
Entelos, Inc.（Rosa and Co. LLC）
Genedata AG
Insilico BIoTechnology AG
Leadscope, Inc.
Nimbus Discovery LLC
Rhenovia Pharma SAS
Schrodinger
Simulation Plus, Inc.

第 8 章章節

調查方法
關於出版商

簡介目錄

Product Code: CMI3915

Computational Biology Market is estimated to be valued at USD 9.13 Bn in 2025 and is expected to reach USD 28.4 Bn by 2032, growing at a compound annual growth rate (CAGR) of 17.6% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 9.13 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	17.60%	2032 Value Projection:	USD 28.4 Bn

Computational biology aims to advance healthcare by developing computational models of diseases, personalizing these models using data from patients, and applying these models to improve the diagnosis and treatment of diseases. These patient models are used to discover novel risk biomarkers, predict disease progression, design optimal treatments, and identify new drug targets for applications such as cancer, cardiovascular disease, and neurological disorders. The development and application of patient-specific, quantitative models can be used to understand, diagnose, and treat disease. Computational medicines can be used for molecular, physiological, and anatomical medicines. The integration of biomedical signal processing, computational modeling, machine learning, and health informatics can be done to develop new approaches in personalized medicine via electronic health records, physiological time series data, and genomics.

Market Dynamics

The increasing launch of new products, mergers, and acquisitions by key market players is expected to drive the global computational biology market growth. For instance, on July 25, 2022, Replay, a U.S.-based genome writing company, received US$ 55 million in seed financing. The round was led by KKR and OMX Ventures, with additional participation from ARTIS Ventures and Lansdowne Partners, SALT, DeciBio Ventures, and Axial. Replay's genomic medicine toolkit encompasses a portfolio of disruptive platform technologies to write and deliver big DNA, including a high payload capacity HSV delivery platform, a hypoimmunogenic cell therapy platform, and a proprietary genome writing platform. The Replay, a U.S.-based genome writing company solves challenges in currently limiting clinical progress including increased payload capacity, off the shelf cell therapies that can reduce the cost of goods, improve production speed, volume and consistency, and expand the potential for genome engineering.

Key features of the study

This report provides an in-depth analysis of the global computational biology market and provides market size (USD Bn) and Compound Annual Growth Rate (CAGR) for the forecast period 2025-2032, considering 2024 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global computational biology market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
The key companies covered as a part of this study include Accelrys, Certara, L.P., Chemical Computing Group Inc., Compugen, Ltd., Entelos, Inc. (Rosa & Co. LLC), Genedata AG, Insilico Biotechnology AG, Leadscope, Inc., Nimbus Discovery LLC, Rhenovia Pharma SAS, Schrodinger, and Simulation Plus, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global computational biology market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global computational biology market.

Market Segmentation

Global Computational Biology Market, By Type
- Cellular and Biological Simulation
- Computational Genomics
- Computational Proteomics
- Pharmacogenomics
- Others (Transcriptomics/Metabolomic)
- Disease Modeling and Simulation Applications
- Drug Discovery
- Drug Development
Global Computational Biology Market, By Tools
- Content/Database
- Analysis Software and Services
- IT Infrastructure (Hardware)
Global Computational Biology Market, By Region
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- U.K.
- Germany
- France
- Spain
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- North Africa
- Central Africa
- South Africa
Company Profiles
- Accelrys
- Certara, L.P.
- Chemical Computing Group Inc.
- Compugen, ltd.
- Entelos, Inc. (Rosa & Co. LLC)
- Genedata AG
- Insilico Biotechnology AG
- Leadscope, Inc.
- Nimbus Discovery LLC
- Rhenovia Pharma SAS
- Schrodinger
- Simulation Plus, Inc.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Tools
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Recent Product Launches
Epidemiology
Merger, Acquisition, and Collaborations
Regulatory Scenario
Key Developments
PEST Analysis

4. Global Computational Biology Market, By Type, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
Cellular and Biological Simulation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Computational Genomics
Computational Proteomics
Pharmacogenomics
Others (Transcriptomics/Metabolomic)
Disease Modeling and Simulation Applications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Drug Discovery
Drug Development

5. Global Computational Biology Market, By Tools, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
Content/Database
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Analysis Software and Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
IT Infrastructure (Hardware)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Computational Biology Market, By Region, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2021-2032
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Tools, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Tools, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Tools, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Tools, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Tools, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (USD Bn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Tools, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2020-2032, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

7. Competitive Landscape

Accelrys
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Certara, L.P.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Chemical Computing Group Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Compugen, ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Entelos, Inc. (Rosa and Co. LLC)
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Genedata AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Insilico Biotechnology AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Leadscope, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Nimbus Discovery LLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Rhenovia Pharma SAS
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Schrodinger
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Simulation Plus, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies